Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir

Y Duan, H Zhou, X Liu, S Iketani, M Lin, X Zhang… - Nature, 2023 - nature.com
Nirmatrelvir is a specific antiviral drug that targets the main protease (Mpro) of SARS-CoV-2
and has been approved to treat COVID-19,. As an RNA virus characterized by high mutation …
被引用次数：32 相关文章

Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir.

Y Duan, H Zhou, X Liu, S Iketani, M Lin, X Zhang… - Nature, 2023 - europepmc.org
Nirmatrelvir is a specific antiviral targeting the main protease (M pro) of SARS-CoV-2, and
has been approved to treat COVID-19 1, 2. As an RNA virus characterized by high mutation …

Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir

Y Duan, H Zhou, X Liu, S Iketani, M Lin, X Zhang… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Nirmatrelvir is a specific antiviral drug that targets the main protease (M pro) of SARS-CoV-2
and has been approved to treat COVID-19 1, 2. As an RNA virus characterized by high …

Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir

Y Duan, H Zhou, X Liu, S Iketani, M Lin, X Zhang… - Nature, 2023 - ideas.repec.org
Nirmatrelvir is a specific antiviral drug that targets the main protease (Mpro) of SARS-CoV-2
and has been approved to treat COVID-191, 2. As an RNA virus characterized by high …

Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir

Y Duan, H Zhou, X Liu, S Iketani, M Lin, X Zhang… - paper.sciencenet.cn
Nirmatrelvir is a specific antiviral targeting the main protease (Mpro) of SARS-CoV-2, and
has been approved to treat COVID-191, 2. As an RNA virus characterized by high mutation …

Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir

Y Duan, H Zhou, X Liu, S Iketani, M Lin, X Zhang… - Nature, 2023 - econpapers.repec.org
Nirmatrelvir is a specific antiviral drug that targets the main protease (Mpro) of SARS-CoV-2
and has been approved to treat COVID-191, 2. As an RNA virus characterized by high …

Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir

Y Duan, H Zhou, X Liu, S Iketani, M Lin, X Zhang… - …, 2023 - ui.adsabs.harvard.edu
Nirmatrelvir is a specific antiviral drug that targets the main protease (M pro) of SARS-CoV-2
and has been approved to treat COVID-19 1, 2. As an RNA virus characterized by high …